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Purpose: Overall prevalence of pulmonary embolism (PE) in patients with deep venous 
thrombosis (DVT) isolated to calf veins is low. However, the prevalence of PE in the 
subgroup of patients with respiratory symptoms and isolated calf vein thrombosis (CVT) 
is tmknown. Such information is important in determining whether patients with CVT 
only and respiratory symptoms hould undergo evaluation for PE. The purpose of this 
study was to determine the prevalence of PE in patients with respiratory symptoms and 
isolated CVT. 
Methods: From 1992 through 1994, all patients assessed by duplex scanning for lower 
extremity DVT were reviewed, and those found to have isolated CVT and lower extrem- 
ity or respiratory symptoms were identified. Patients who had respiratory symptoms or 
later developed respiratory symptoms in addition to lower extremity symptoms under- 
went pulmonary angiography or ventUation/perfusion (V/Q) scanning. Positive results 
on pulmonary arteriograms or "high probability" V /Q  scans were considered diagnostic 
of PE. 
Results: There were 105 patients with isolated CVT and symptoms. Twenty-six patients 
had respiratory symptoms; nine (35%) had PE and two died. Seventy-nine patients had 
only lower extremity complaints; five later developed respiratory symptoms. All five had 
PE and none had progression of CVT on repeat duplex scanning. Neither age, gender, 
prior DVT/PE, obesity, pregnancy, medication, known malignancy, smoking, recent 
surgery, or trauma predicted PE. 
Conclusions: Patients with respiratory symptoms and duplex diagnosed isolated CVT 
have a high prevalence of PE and require pulmonary angiographic or V /Q  scanning to 
rule out PE. (J Vasc Surg 1997;25:39-45.) 
Duplex scanning is the preferred method for eval- 
uation of  suspected lower extremity deep venous 
thrombosis (DVT). 1 Its wide availability and accep- 
tance and the potential lethal complication of pulmo- 
nary embolism (PE) in untreated DVT make it one 
of the most frequently used vascular laboratory ex- 
aminations. Indeed, with the addition of  color flow, 
diagnostic accuracy for DVT has improved to the 
point where even calf vein thrombosis (CVT) can be 
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detected with sensitivities and specificities approach- 
ing 100%. 2,3 
Although CVT may be found in association with 
thrombosis of more proximal venous segments, 4-6 
isolated CVT is not an infrequent finding on venous 
duplex scanning. 7 Although the overall risk of PE is 
assumed to be low in patients with isolated CVT, s-l° 
the prevalence of PE in the subgroup of patients with 
isolated CVT and respiratory symptoms may bemore 
significant. In addition, although it is clear that lower 
extremity duplex scanning performed solely for respi- 
ratory symptoms yields a low positive diagnosis of 
DVT, it does not necessarily follow that patients with 
duplex-diagnosed isolated CVT and respiratory 
symptoms will have a low prevalence of PE. The 
purpose of  this study was to determine the preva- 
lence of  PE in patients with respiratory symptoms 
and isolated CVT diagnosed by venous duplex scan- 
ning. The results may have important implications in 
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Table I. Presenting symptom in patients 
with isolated CVT with and without PE 
CVT alone CVT with PE 
(n = 91) (n = 14) 
Leg Pain only 38 3 
Swelling only 20 2 
Pain and swelling 16 0 
74 (81.3%) 5 (35.7%)* 
Respiratory Dyspnea 11 5 
Chest pain 3 2 
Respiratory failure 3 2 
17 (18.7%) 9 (64.3%)* 
*p < 0.001 by X 2 analysis. 
determining whether patients with respiratory symp- 
toms and isolated CVT should routinely undergo 
evaluation for PE. 
PATIENTS AND METHODS 
All patients found to have isolated CVT by ve- 
nous duplex scanning between January, 1992, and 
December, 1994, were identified from review of vas- 
cular laboratory records at the Oregon Health Sci- 
ences University Hospital in Portland. 
All duplex examinations were performed by reg- 
istered vascular technologists using an Acuson XP- 
128 color-flow duplex scanner. Iliac, femoral, and 
popliteal and calf veins (anterior tibial, posterior tib- 
ial, peroneal, and solcal veins) were routinely evalu- 
ated. 11 A 3-MHz transducer was used to insonate the 
iliac veins. Five-megahertz transducers were used to 
examine the infrainguinal veins, although occassion- 
ally a 3-MHz probe was required to examine the 
region of the adductor canal in patients with very 
large legs. CVT was diagnosed using the criterion of 
incompressibility, abnormal or absent color-flow im- 
ages, and failure to increase flow with distal augmen- 
tation within an insonated calf vein segment. 12 
Only patients with DVT limited to the calf and 
with lower extremity or respiratory complaints were 
included in this study. Lower extremity symptoms 
were defined as pain, swelling, or pain with swelling. 
Respiratory symptoms were defined as dyspnea, pleu- 
ritic chest pain, or respiratory failure. Excluded were 
patients with (1) thrombosis propagation into the 
popliteal vein or higher on subsequent venous du- 
plex examinations; (2) evidence of prior DVT in the 
proximal vein segments of the ipsilateral extremity; 
(3) evidence of proximal DVT in the contralateral 
extremity; and (4) asymptomatic isolated CVT dis- 
covered in screening examinations ofpatients uch as 
immoblized trauma victums, and postoperative or- 
thopaedic or neurosurgical patients thought o be at 
high risk for DVT. 
Patients with respiratory symptoms and isolated 
CVT underwent either ventilation/perfusion (V/Q) 
scanning or pulmonary arteriographic s anning. Pul- 
monary embolism was diagnosed by either pulmo- 
nary angiogram demonstrating a filling defect in the 
pulmonary artery or its branches, or a "high proba- 
bility" V /Q  scan demonstrating segmental perfusion 
defect(s) without corresponding ventilation abnor- 
malities.13,14 
Patient characteristics and risk factors were also 
assessed for association of symptomatic CVT with 
symptomatic PE. Statistical analysis was performed 
using parametric (Student's t test) and nonparamet- 
ric (×2) methods. 
RESULTS 
One hundred five patients with isolated CVT and 
respiratory or lower extremity symptoms were iden- 
tiffed. There were 51 men (48.6%) and 54 women 
(51.4%), with a mean age of 62.4 + 15.1 years 
(range, 21 to 92 years). Of the 105 patients, 98 
(93.3%) had unilateral and 7 (6.7%) had bilateral 
CVT. There were 124 calf vein segments with 
thrombus in the 112 limbs, including 75 peroneal 
(60.5%), 37 posterior tibial (29.8%), 3 anterior tibial 
(2.4%), 6 gastrocnemius (4.8%), and 3 soleal veins 
(2.4%). 
Twenty-six of the 105 patients (24.7%) with iso- 
lated CVT and symptoms had respiratory symptoms 
either alone or in combination with lower extremity 
symptoms (Table I). All 26 underwent either pulmo- 
nary angiographic or V /Q  scanning, and nine (35%) 
were diagnosed with PE. The diagnosis of PE was by 
high probability V /Q  scan in six patients and by 
pulmonary angiographic scan in three patients. In 
the 17 patients in whom the diagnosis of PE was 
excluded, five underwent pulmonary angiographic 
scans and 12 underwent V /Q scanning (eight low 
probabili~, and four indeterminant VQ scans). 
Seventy-nine of the patients (75.3%) had lower 
extremity symptoms only (Table I). Five of these 79 
patients (6.3%) later developed respiratory symptoms 
at a mean of 2.7 days (range, 1 to 7 days) after their 
duplex diagnosis of isolated CVT. All five of these 
patients were found'to have PE (three by V /Q scan- 
ning and two by pulmonary angiography), and none 
had been treated with anticoagulation therapy after 
their initial duplex diagnosis of isolated CVT. 
Patient characteristics and potential risk factors 
for DVT in the 105 patients with isolated CVT and 
symptoms are summarized in Tables II and III. Al- 
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Table II. Comparison of patients with 
isolated CVT with and without PE 
CVT alone CVT with PE 
(n = 91) (n = 14) p* 
Mean age 62.89 _+ 15.48 59.31 -+ 12.81 NS 
Male 45 (49.5%) 6 (42.9%) NS 
Female 46 (50.5%) 8 (57.1%) NS 
Inpatient 40 (44.0%) 11 (78:6%) <0.05 
Outpatient 51 (56.0%) 3 (21.4%) <0.05 
*Student's t test for mean age; ×2 analysis for gender, and hospital 
status. 
though patients with isolated CVT and PE were 
more often inpatients (78.6% vs 48.4%, p < 0.05), 
there was no difference in those with and without PE 
with regard to age, gender, prior DVT/PE,  obesity, 
pregnancy/postpartum, hormonal medication, im- 
mobility, known malignancy, congestive heart fail- 
ure, smoking, or recent surgery or trauma. However, 
risk factors including prior DVT and prolonged im- 
mobility did approach statistical significance, and the 
lack of difference may represent a potential type II 
statistical error due to the smaller number of patients 
in the PE group. 
The 14 patients with PE had CVT in 17 calf vein 
segments, including 12 peroneal (70.6%), 4 poste- 
rior tibial (23.5%), and 1 anterior tibial veins (5.9%). 
None of the patients with CVT in the soleal or 
gastrocnemius vein were diagnosed with PE. How- 
ever, there was no statistical correlation between 
CVT location and the development of PE. 
Twelve of the 14 patients with PE were anticoag- 
ulated and two underwent placement of an inferior 
vena caval filter. Two patients with PE (14.3%) died 
during the same hospitalization. Although both 
deaths were a result of respiratory failure, neither 
could be attributed with complete confidence to PE 
because there were other concurrent diagnoses that 
may have contributed to their deaths and autopsies 
were not performed. Thirty-eight additional patients 
with isolated CVT (33 with extremity symptoms and 
5 with respiratory symptoms) were also treated with 
anticoagulation therapy, and none developed new or 
additional respiratory symptoms that led to a new or 
repeated evaluation for PE. 
DISCUSSION 
The clinical significance of DVT limited to the 
calf veins is controversial. Although acute DVT can 
occur anywhere in the deep venous system of the 
lower extremity, ls 16 it is well established the major- 
ity originate in infrapopliteal veins or muscular si- 
nuses with a thrombotic process that may subse- 
Table I I I .  Comparison of risk factors for 
patients with isolated CVT with and 
without PE 
CVTalone CVTwith  PE 
(n = 91) (n = 14) p* 
Prior DVT 9 (9.9%) 3 (21.4%) NS 
Prior PE 4 (4.4%) 2 (14.3%) NS 
Obesity 14 (15.4%) 2 (14.3%) NS 
Pregnancy/postpartum 4 (4.4%) 0 (0%) NS 
Estrogen 16 (17.6%) 3 (21.4%) NS 
Trauma 9 (9.9%) 1 (7.1%) NS 
Postoperative 28 (30.8%) 4 (28.6%) NS 
Prolonged immobility 32 (35.2%) 7 (50.0%) NS 
Malignancy 19 (20.9%) 4 (28.6%) NS 
Cardiac disease 25 (27.5%) 3 (21.4%) NS 
Tobacco 42 (46.2%) 7 (50.0%) NS 
.×2 analysis. 
quently extend into the more proximal veins. 17,1s 
This is supported by the observation that a significant 
number of patients with proximal DVT have con- 
cominant calf vein thrombi, s,19 In addition, as many 
as 32% of patients initially diagnosed with CVT show 
evidence of propagation i to proximal veins on sub- 
sequent venous duplex examinations? ° 
Pulmonary emboli in patients with DVT appar- 
ently limited to the calf has been noted in previous 
reports. In 1976 Moreno-Cabral et al. 2° found a 33% 
incidence of clinically "silent" PE by pulmonary arte- 
riographic or serial ung scans in patients with CVT. 
Similarily, Browse and Lea-Thomas 21 in 1976 re- 
ported nonlethal pulmonary emboli n patients with 
CVT only and concluded that the source of emboli 
in about 25% of patients with PE was DVT limited to 
the infrapopliteal deep venous system. In addition, 
two necropsy studies have reported fatal pulmonary 
emboli arising from calf vein venous thrombosis.IS,22 
Despite these early reports and others, 23-2s and 
the fact that it is generally agreed that a number of 
cases of proximal DVT originate in the infrapopliteal 
veins, many physicians have not regarded calf vein 
thrombi without propagation i to the popliteal vein 
as important precursors of pulmonary emboli and 
therefore important enough to merit treatment with 
anticoagulation therapy. In 1988 Philbrick and 
Becker 8concluded that there was no convincing evi- 
dence that significant pulmonary emboli occurred in 
patients with isolated CVT and that pulmonary em- 
boli were only associated with propagation of 
thrombi nto the popliteal vein or higher. 
Obviously, the data in this report cannot be used 
to determine the overall prevalence of pulmonary 
emboli in patients with isolated CVT. Our patients 
with only lower extremity symptoms were not rou- 
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tinely evaluated for PE unless they subsequently de- 
veloped respiratory symptoms, and patients with 
asymptomatic calf vein thrombi were not included in 
this study. Nevertheless, our data strongly argue 
against the conclusions of Philbrick and Becker. Al- 
though none of the patients in our study conclusively 
died solely from their PE, all had calf vein thrombi by 
duplex examination, some had new respiratory symp- 
toms that prompted an evaluation for pulmonary 
embolism, and none had duplex evidence of throm- 
bus propagation into the popliteal or more proximal 
veins. 
There is also no consensus regarding the treat- 
ment of isolated CVT. The uncertain natural history 
of isolated CVT combined with the dangers and 
inconvience and expense of hospitalization for tradi- 
tional intravenous heparin followed by warfarin anti- 
coagulation has resulted in recommendations for de- 
laying treatment of isolated CVT with anticoagulation 
therapy until proximal extension has been docu- 
mented by serial duplex studies. 8,26 Others have, 
however, advocated routine anticoagulation to re- 
duce the potential for propagation. 12,27 In this study 
3 5% of the patients who presented with isolated CVT 
and respiratory symptoms and 100% of patients who 
presented with lower extremity symptoms and iso- 
lated CVT and later developed respiratory symp- 
toms, actually had PE. Converesely, no patient 
treated with anticoagulation therapy developed new 
or worse respiratory symptoms. These observations 
suggest more aggressive use of anticoagulation ther- 
apy in patients with isolated CVT may be indicated. 
There are now apparently effective and safe outpa- 
tient treatment protocols with low-molecular-weight 
heparin for anticoagulant treatment of DVT. 28 Po- 
tential Food and Drug Administration approval for 
these drugs for outpatient reatment of DVT, cou- 
pled with possibly improved preservation of venous 
valvular function and new natural history data for 
CVT as detailed in this report, may, in the opinions 
of many physicians, shift the risk/benefit ratio of 
anticoagulant treatment of CVT more clearly in favor 
of anticoagulation therapy. 
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DISCUSSION 
Dr. D. Eugene Strandness, Jr. (Seattle, Wash.). One 
of the more difficult areas in the field of DVT has been the 
relationship between CVT and PE. It is my view that most 
investigators have adopted the position that if pulmonary 
emboli do arise from isolated calf vein thrombi, they will be 
silent and be of little consequence. Clearly, and I don't 
think the authors disagree with this, calf vein thrombi are 
not associated with sudden death from PE. We associate 
this phenomenon with thrombi arising from the more 
proximal larger veins. 
I, like most people interested in this disease, have had 
an ambivalent feeling about isolated calf disease, and this is 
for the following reasons: 
First, its importance as a cause of the postthrombotic 
syndrome has not been established. This is fascinating 
given all of our experience in the whole field of DVT. The 
prevalence of isolated CVT is very low, at least in our 
studies; less than 5% of our population who come to the 
hospital with DVT are found to have isolated CVT. 
Second, I have not found a case in which it appeared 
that a pulmonary embolus was caused by disease of the calf 
veins alone. However, I must admit that this statement is 
made on the basis of my impression alone and not on any 
systematic study of the problem. 
The other very weak aspect of this whole problem is 
the diagnosis of PE. Clearly, the only true gold standard 
here is pulmonary artetiography. Although I realize that 
V /Q  scans are commonly done, my confidence in this 
procedure as a diagnostic test has been very poor. Clearly, 
one has to have a very clear mismatch to make that diagno- 
sis. 
The recommendation to treat, given the data here, is 
not unreasonable. However, most physicians who do treat 
do so on the basis that 20% of the calf vein thrombi will 
propagate without herapy. Those who don't treat simply 
recommend repeat scans to document stability and lysis 
without progression. It would appear that both approaches 
have been successful, but we really don't know whether 
this is the case. 
I have several questions for the authors. Would you 
recommend, indeed push for, a pulmonary arteriogram 
when these occasions arise? 
Because you now recommend therapy, although you 
didn't seem to be very strong about his, how long should 
the therapy be carried out? In other words, anybody with 
pulmonary emboli from more proximal veins would be 
treated from anywhere from 3 to 6 months with warfarin. 
Do you believe that patients in whom PE and CVT are 
suspected can be safely treated as an outpatient? The reason 
I bring up this subject is because now with the availability 
of low-molecular-weight heparin, there is increased pres- 
sure to treat all of these patients as outpatients and pressure 
not keep them in the hospital. 
Finally, do you think it's possible that the subset of 
patients in your study have thrombi at other sites, and 
these were embolized, and not£rom the calf?. This may be a 
impossible to answer. However, we all know that this can 
occur. Pulmonary emboli can occur with the site of the 
thrombus being clean after the thrombus has left. 
Dr. Marc A. Passman. First, I would agree with Dr. 
Strandness that the preferred method of diagnosing pul- 
monary embolus is with pulmonary arteriography, al- 
though V /Q scans do appear quite useful in cases in which 
there is high clinical suspicion of PE. The use of V /Q  scan, 
namely, high probability V /Q  scan, does appear to be an 
appropriate method of diagnosing PE in selected cases. 
The second and third question referred to recom- 
mended therapy, namely, duration and whether patients 
should be treated as an outpatient. We feel that patients 
with isolated CVT should be treated like all other patients 
with DVT, namely, that therapy should be initiated in the 
hospital with heparin and then transition to warfarin for a 
duration of approximately 3 months, depending on the 
clinical situation. I agree that outpatient low-molecular- 
weight heparin may be a recommendation in the near 
future. 
Finally, there is a question about whether a subset of 
our patients may have had thrombi that originated in other 
sites. Although this origin is conceivable, we were very 
careful about reviewing the duplex examinations to rule 
out the possibility of any residual or proximal clot. 
Dr. Lazar J. Greenfield (Ann Arbor, Mich.). I con- 
gratulate the authors on addressing a very important issue. 
A number of years ago we were interested in the popula- 
tion of patients who are taking anticoagulation medication 
who had emboti in spite of that treatment, and learned that 
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patients who have propagation of their thrombus that is 
nonattached, that is, a free-floating tail, seemed to have a 
higher predisposition. So I 'm interested in whether or not 
you have any correlation with any extension or appearance 
of free-floating. It's not too surprising if you have patients 
who have respiratory symptoms that the only residual at- 
tachment might be in the calf for a thrombus that had 
propagated above that level. So I think it's hard to know at 
the time that you see the patient what the original extent of 
the thrombus was. 
The second question I have for you is in relationship to 
trying to predict he behavior of calf vein thrombi. One of 
the clinical parameters that has been helpful to me is 
whether or not the patient is ambulatory. It wasn't a 
surprise that most of your patients who were in the embolic 
population were hospitalized, and I wonder whether you 
have looked at the correlation of PE between the ambula- 
tory population and those who remained immobilized. 
Dr. Passman. To address the first question regarding 
free-floating thrombi on our patients, all had clots con- 
fined to below the knee. Any patient who had had evidence 
of propagation or free-floating clot per se were excluded 
from the study. 
The second question was asked in regard to whether 
patients were ambulatory or nonambulatory at the time of 
their initial presentation. I do not have further information 
concerning that issue except o say that we defined inpa- 
tient versus outpatient at the time of presentation, ot at 
the time the diagnosis was made. 
Dr. Ron Lewis (Montreal, Quebec, Canada). I would 
like to congratulate Dr. Passman on his paper and for 
bringing to our attention the distinction between different 
types of CVT. In our laboratory we have routinely distin- 
guished between tibial peroneal DVT, which are closer to 
popliteal than crural vein or isolated intramuscular calf vein 
DVT. Have you made this distinction? 
Secondly, were you able by correlation with your pul- 
monary angiograms, or perhaps computed tomographic 
angiograms, to define whether these pulmonary emboli 
were in fact merely associated with or originated from the 
calf vein? It is clear from the original autopsy studies pub- 
lished in the Lancetmany years ago that in 30% of patients 
who had PE you could not identify an anatomic source, 
presumably because of prior embolization, as Dr. Strand- 
ness referred to. 
Dr. Passman. The first question was in terms of dis- 
tinction between the tibial peroneal versus the soleal gas- 
trocnemius veins. In general, ability to image the fibial 
peroneal veins is better than ability to image the muscular 
sinus veins. That may explain why the tibial and peroneal 
veins were the more common sites for the CVT than 
muscular sinus veins. 
The second question concerned the review of the V /Q 
scans and the angiograms. We believe that the V /Q scans 
and the clinical presentation were associated, but may or 
may not have been directly related. It's difficult, we ac- 
knowledge, to know for sure. 
Dr. Norman L. Browse (London, U.K.). I have never 
understood why we divide patients with DVT or PE into 
those with symptoms and those without, because they have 
the same underlying disease, and we are never certain of 
the cause of the symptoms in either case. There is not 
much published ata on the incidence of PE in patients 
who have symptomatic DVT, but there are data on the 
incidence of PE in asymptomatic DVT. In the 1970s, using 
V /Q scanning and fibrinogen uptake test, a number of 
investigations showed that 30% of CVT were associated 
with PE. That is a much higher incidence than the 13% you 
have just described. Do you think this is a real difference? Is
the asymptomatic DVT more likely to produce emboli 
than the symptomatic, a belief that used to be held when, 
in the 1940s and 1950s we talked about thrombophlebitis 
and phlebothrombosis. 
Dr. Passman. Well, I think that that addresses the 
question of what is clinically significant and what is silent 
PE. The studies you are referring to were deemed clinically 
silent PE. I think that it is important to make a distinction 
that patients with isolated CVT can be grouped presum- 
ably into three categories, that is, patients who are asymp- 
tomatic, patients who are symptomatic with leg com- 
plaints, and patients who are symptomatic with respiratory 
or leg complaints. There may be a difference in inherent risk 
of PE, and that is clinically significant PE, in all these groups. 
The group who presented with lower extremity com- 
plaints did not undergo routine V /Q scanning. The inci- 
dence of clinically silent PE may indeed have been higher 
in this group. 
Dr. Robert M. Zwolak (Lebanon, N.H.). That was a 
very nice paper. Your conclusions, however, are made on 
the basis of your duplex findings, and I wonder whether 
you might elaborate a little bit more on your confidence 
level in the duplex diagnosis of CVT. Certainly, the litera- 
ture shows that the accuracy of duplex scanning for asymp- 
tomatic proximal DVT is a lot less than the superb accuracy 
in symptomatic limbs with proximal DVT. The literature 
for the accuracy of duplex diagnosis of calf vein DVT, at 
least compared to venography, is not a very extensive or 
convincing literature. So could you tell us how you vali- 
dated the accuracy of your DVTs? Do you have 
venograms? If you don't have venograms, how are you 
confident hat these are accurate studies? Most of us have 
pretty much given up on routinely studying the anterior 
tibial veins, but I see that that is included in your protocol. 
Finally, assuming you believe in your confidence of the 
diagnosis, are the criteria the same? The criteria that we use 
for diagnosis in the proximal venous system of compress- 
ibility, spontaneous flow, augmentation, and compression, 
are those criteria the same in the calf?. 
Dr. Passman. Our study did not address the validation 
of the ability of the duplex scans to detect CVT, that is, 
venograms were not obtained to further support he diag- 
nosis. We accepted the fact that all these patients had 
isolated CVT on the basis of their duplex findings and on 
the basis of the standard criteria s presented. 
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Dr. Andrew N. Nicolaides (London, U.K.). I very 
much enjoyed your paper, and I would like to ask two 
questions. 
The first question is related to those patients who had 
symptomatic solated calf thromboses and of whom 6% 
developed respiratory symptoms; the patients in whom you 
found PE. I would like to know whether these patients 
were undergoing treatment with heparin before the respi- 
ratory symptoms developed? 
The second question is related to what Dr. Strandness 
implied, that in those patients who had respiratory symp- 
toms and you found isolated calf thrombosis, maybe there 
was a thrombus in the proximal veins that had disappeared 
by the time you investigated them. Now, surely the ques- 
tion that needs to be asked is this: in all the patients that 
came to your hospital with respiratory symptoms in whom 
you diagnosed pulmonary embolus, if you scanned their 
legs, in what proportion would you find isolated calf 
thromboses and in what proportion would you find proxi- 
mal thromboses? 
Dr. Marc A. Passman (Portland, Ore.). The first 
question referred to the patients who had isolated CVT 
and lower extremity symptoms, 6% of whom developed 
respiratory symptoms; all of them were later diagnosed 
with PE. None of these patients had been undergoing 
anticoagulation treatment at the time the respiratory 
symptoms developed. 
The second issue concerns the possibility that som e of 
these patients had had a proximal clot that embolized. This 
is obviously a possibility but does not detract from the 
basic conclusion of the study that patients whose only 
duplex finding is isolated CVT and who also have respira- 
tory symptoms will frequently have a positive diagnostic 
study for PE should one be performed. 
